{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:35:15Z","timestamp":1789767315632,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600455"],"award-info":[{"award-number":["81600455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.intimp.2020.106208","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T23:03:57Z","timestamp":1579215837000},"page":"106208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice"],"prefix":"10.1016","volume":"80","author":[{"given":"Jin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.dld.2017.08.022","article-title":"Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity","volume":"50","author":"van den Berg","year":"2018","journal-title":"Dig. Liver Dis.: Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver"},{"issue":"11","key":"10.1016\/j.intimp.2020.106208_b0010","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106208_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000336669","article-title":"Nonalcoholic fatty liver disease\/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment","volume":"30","author":"Milic","year":"2012","journal-title":"Dig. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.intimp.2020.106208_b0030","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"10.1016\/j.intimp.2020.106208_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2020.106208_b0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1440-1746.2011.07018.x","article-title":"Pathophysiology guided treatment of nonalcoholic steatohepatitis","volume":"27","author":"Nguyen","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106208_b0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","article-title":"Non-alcoholic fatty liver disease pathogenesis: the present and the future","volume":"41","author":"Petta","year":"2009","journal-title":"Dig. Liver Dis.: Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver"},{"issue":"5","key":"10.1016\/j.intimp.2020.106208_b0050","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2020.106208_b0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106208_b0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.it.2013.04.005","article-title":"The innate immune response during liver inflammation and metabolic disease","volume":"34","author":"Bieghs","year":"2013","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/met.2013.0120","article-title":"TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls","volume":"12","author":"Kiziltas","year":"2014","journal-title":"Metabolic Syndrome Related Disord."},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0070","first-page":"78","article-title":"[Effects of soothing liver and invigorating spleen recipes on the mRNA and protein expression of TLR4 in hepatic tissues of rats with NASH]","volume":"36","author":"Yang","year":"2013","journal-title":"Zhong yao cai = Zhongyaocai = J. Chinese Med. Mater."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0075","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastrointestinal Liver Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2020.106208_b0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1440-1681.12241","article-title":"Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice","volume":"41","author":"Liu","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2020.106208_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2012.01.010","article-title":"Iron overload-induced rat liver injury: involvement of protein tyrosine nitration and the effect of baicalin","volume":"680","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1159\/000447820","article-title":"Baicalin attenuates alcoholic liver injury through modulation of hepatic oxidative stress, inflammation sonic hedgehog pathway in rats","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106208_b0095","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/np100389z","article-title":"Protective effects of baicalin against ischemia\/reperfusion injury in rat liver","volume":"73","author":"Kim","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.intimp.2020.106208_b0100","doi-asserted-by":"crossref","first-page":"6169128","DOI":"10.1155\/2017\/6169128","article-title":"Baicalin ameliorates experimental liver cholestasis in mice by modulation of oxidative stress, inflammation, and NRF2 transcription factor","volume":"2017","author":"Shen","year":"2017","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.106208_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.etp.2011.08.005","article-title":"Baicalin prevents cadmium induced hepatic cytotoxicity, oxidative stress and histomorphometric alterations","volume":"65","author":"Wen","year":"2013","journal-title":"Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie"},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0110","first-page":"48","article-title":"Baicalin attenuates high fat diet-induced insulin resistance and ectopic fat storage in skeletal muscle, through modulating the protein kinase B\/Glycogen synthase kinase 3 beta pathway","volume":"14","author":"Xi","year":"2016","journal-title":"Chinese J. Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12032-015-0527-9","article-title":"Effect of baicalin-copper on the induction of apoptosis in human hepatoblastoma cancer HepG2 cells","volume":"32","author":"Li","year":"2015","journal-title":"Med. Oncol. (Northwood, London, England)"},{"key":"10.1016\/j.intimp.2020.106208_b0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbi.2017.10.010","article-title":"Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP\/NLRP3 inflammasome activation","volume":"278","author":"Zhang","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2020.106208_b0125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopha.2018.01.041","article-title":"Baicalin alleviates IL-1beta-induced inflammatory injury via down-regulating miR-126 in chondrocytes","volume":"99","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2020.106208_b0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/molecules21040444","article-title":"LC-UV Determination of baicalin in rabbit plasma and tissues for application in pharmacokinetics and tissue distribution studies of baicalin after intravenous administration of liposomal and injectable formulations","volume":"21","author":"Wei","year":"2016","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.intimp.2020.106208_b0135","first-page":"3623","article-title":"Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes","volume":"9","author":"Wei","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.intimp.2020.106208_b0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/00498251003663724","article-title":"Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives","volume":"40","author":"Srinivas","year":"2010","journal-title":"Xenobiotica; Fate Foreign Compound. Biol. Syst."},{"issue":"4","key":"10.1016\/j.intimp.2020.106208_b0145","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/21691401.2017.1282496","article-title":"Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications","volume":"45","author":"Panahi","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2020.106208_b0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejphar.2008.02.081","article-title":"Protective effect of baicalin against lipopolysaccharide\/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1","volume":"587","author":"Wan","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106208_b0155","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"13","key":"10.1016\/j.intimp.2020.106208_b0160","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106208_b0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13318-018-0509-3","article-title":"Pharmacokinetics and bioavailability enhancement of baicalin: a review","volume":"44","author":"Huang","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.intimp.2020.106208_b0170","doi-asserted-by":"crossref","DOI":"10.2174\/1871520619666190705120011","article-title":"Nanoliposomal encapsulation enhances in vivo anti-tumor activity of niclosamide against melanoma","author":"Hatamipour","year":"2019","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.intimp.2020.106208_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.04.016","article-title":"Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma","volume":"20","author":"Korani","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.106208_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071747","article-title":"Preparation, characterization, pharmacokinetics and biodistribution of Baicalin-loaded liposome on cerebral ischemia-reperfusion after i.v. administration in rats","volume":"23","author":"Li","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/cmi.2014.2","article-title":"The role of neutrophils in the development of liver diseases","volume":"11","author":"Xu","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106208_b0195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.intimp.2020.106208_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123891","article-title":"Modulation of chemokine- and adhesion-molecule gene expression and recruitment of neutrophil granulocytes in rat and mouse liver after a single gadolinium chloride or zymosan treatment","volume":"19","author":"Ahmad","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.intimp.2015.01.009","article-title":"Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response","volume":"26","author":"Luan","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106208_b0210","doi-asserted-by":"crossref","first-page":"35851","DOI":"10.1038\/srep35851","article-title":"Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_bib246","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.intimp.2020.106208_b0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/liv.12315","article-title":"Toll-like receptors and liver disease","volume":"34","author":"Kesar","year":"2014","journal-title":"Liver Int.: Off. J. Int. Assoc. Study Liver"},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.intimp.2020.106208_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2020.106208_b0240","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"5","key":"10.1016\/j.intimp.2020.106208_b0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2079","article-title":"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling","volume":"7","author":"O'Neill","year":"2007","journal-title":"Nat. Rev. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919325482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919325482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T01:06:23Z","timestamp":1744506383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919325482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":48,"alternative-id":["S1567576919325482"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106208","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106208"}}